HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

TXMD

TherapeuticsMD, Inc. (NASDAQ)

Healthcare — Drug Manufacturers - Specialty & Generic

TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States and internationally. Its products portfolio includes IMVEXXY for the treatment of moderate-to-severe dyspareunia, a symptom of vulvar and vaginal atrophy due to menopause; BIJUVA to treat moderate-to-severe vasomotor symptoms due to menopause in women with a uterus; and ANNOVERA, a ring-shaped contraceptive vaginal system. The company also offers prescription prenatal vitamin products under the BocaGreenMD and vitaMedMD brand names. It has a license agreement with Mayne Pharma Group Limited. The company sells its products through wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.

None
$2.02
$-0.02 (-0.98%)
Sign in to add TXMD to a watchlist or set price alerts.

Price History

52-Week Range

Fundamentals

Market Cap$25.00M
P/E Ratio (TTM)216.00
Forward P/E6.17
EPS (TTM)$0.01
Dividend Yield-
Profit Margin5.34%
Revenue Growth84.20%
ROE0.32%
Debt/Equity21.62
Recommendation None
Analyst Target-
Analysts-
Indexes NASDAQ

Technical Indicators

RSI (14)62.3
Beta0.60
SMA 20-
SMA 40-
52-Week High$2.95
52-Week Low$0.99
50-Day Avg$2.06
200-Day Avg$1.86
Avg Volume38.7K
Volume21.1K

Performance Analysis

NEUTRAL

TXMD presents a mixed picture with both positive and negative indicators.

~ Trading at 53% of its 52-week range.
+ RSI at 62.3 shows positive momentum.
~ Price dropped below the 50-day average but remains above the 200-day — possible short-term weakness.
- P/E of 216.0 is elevated — the market expects high growth or it may be overvalued.
+ Strong revenue growth of 84.2% year-over-year.
~ Wall Street consensus is "none".

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Jul 02, 2026 13:35 UTC

Back to Screener Export Report